Press Releases
Search
-
20 Apr 2017
The FilmArray® Respiratory Panel 2 plus (RP2plus) gets CE marked
bioMérieux, a world leader in the field of in vitro diagnostics, today announced that the FilmArray® Respiratory Panel 2 plus (RP2plus) is CE marked. The FilmArray® RP2plus panel tests for 22 pathogen...
-
20 Apr 2017
bioMérieux – First-Quarter 2017 Business Review
Strong sales dynamic in first-quarter 2017, with sales up 13.7% at constant exchange rates and scope of consolidation: €568 million in sales Up 16.3% as reported Equipment sales up sharply Accelerated...
-
05 Apr 2017
bioMérieux receives FDA 510(k) clearance for its BacT/ALERT® VIRTUO™ fully automated blood culture system
bioMérieux, a major player in the field of in vitro diagnostics, and the world leader in microbiology, announces that BacT/ALERT® VIRTUO™, its fully automated blood culture system, has received 510(k)...
-
01 Mar 2017
bioMérieux – 2016 Financial Results
Remarkable growth in sales in 2016, up 9.6% at constant exchange rates and scope of consolidation: €2,103 million in sales Up 7.1% as reported Contributive operating income before non-recurring items:...
-
01 Mar 2017
bioMérieux – 2016 Financial Results
Remarkable growth in sales in 2016, up 9.6% at constant exchange rates and scope of consolidation: €2,103 million in sales Up 7.1% as reported Contributive operating income before non-recurring items:...
-
24 Feb 2017
bioMérieux’s VIDAS® B•R•A•H•M•S PCT™ becomes the first FDA-cleared procalcitonin assay as an aid for antibiotic stewardship in respiratory infections and sepsis
bioMérieux, a world leader in the field of in vitro diagnostics, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded use of VIDAS® B•R•A•H•M•S PCT™, an auto...